SAVITZ RYAN (EVP, CFO & CBO) sold 20K shares of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $903.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0001992324-25-000005
Officer· EVP, CFO & CBO
Since Feb 2026
+20K
Net shares
Net buyer
$903.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
40K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$8.44
Trade value
$168.80K
% of position
New position
12/4/2025
0.00→20K
Common Stock
Direct
Shares
−20K
Price / share
$45.18
Trade value
$903.60K
% of position
New position
12/4/2025
20K→0.00
Total
Net shares
+0.00
Net value
-$734.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2025 | M · Option Exercise | +20K | $8.44 | $168.80K | New position | 0.00 | 20K |
| Common Stock Direct | 12/4/2025 | S · Sale | −20K | $45.18 | $903.60K | New position | 20K | 0.00 |
| Total | +0.00 | -$734.80K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20K shares
Shares
+20K
Strike price
8.44
Held after
84.77K
Exercisable
—
12/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20K shares | 12/4/2025 | M · Option Exercise | +20K | 8.44 | — | 84.77K |